Fraction Metabolized
Fraction Metabolized - Related Videos
08:22
Preparation of Mitochondrial Enriched Fractions for Metabolic Analysis in Drosophila
0 Views •
Cited by 12 •
2015
Mitochondria play central roles in the regulation of metabolism and homeostasis. Subtle changes in mitochondrial metabolism that affect organismal physiology could be difficult to detect in whole organism metabolomics studies. Here we describe an isolation method that enhances the detection of subtle metabolic shifts in Drosophila melanogaster.
11:44
Metabolic Labeling and Membrane Fractionation for Comparative Proteomic Analysis of Arabidopsis thaliana Suspension Cell Cultures
0 Views •
Cited by 6 •
2013
Here we describe a robust method for the fractionation of plant plasma membranes into detergent resistant and detergent soluble membranes based on a mixture of unlabeled and in vivo fully 15N labeled Arabidopsis thaliana cell cultures. The procedure is applied for comparative proteomic studies to understand signaling processes.
05:41
Metabolic Profile Analysis of Zebrafish Embryos
0 Views •
Cited by 42 •
2013
Zebrafish represent a powerful vertebrate model that has been under-utilised for metabolic studies. Here we describe a rapid way to measure the in vivo metabolic profile of developing zebrafish that allows the comparison of different mitochondrial function parameters between genetically or pharmacologically manipulated embryos, thereby increasing the applicability of this organism.
01:14
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
0 Views •
2025
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
10:09
Fractional Distillation
0 Views •
2023
Source: Laboratory of Dr. Nicholas Leadbeater — University of Connecticut Distillation is perhaps the most common laboratory technique employed by chemists for the purification of organic liquids. Compounds in a mixture with different boiling points separate into individual components when the mixture is carefully distilled. The two main types of distillation are "simple distillation" and "fractional distillation", and both are widely used in organic chemistry laboratories. Simple distillation...
FAQs
Enzyme inhibition can reduce the metabolic contribution to drug clearance, potentially increasing the amount of parent drug that remains available for exposure. Induction can produce the opposite shift by increasing biotransformation activity. Because the fraction metabolized indicates how much clearance depends on these pathways, it helps clinicians anticipate whether an interacting drug may meaningfully alter therapy.
Fraction metabolized must be interpreted alongside the alternative route of unchanged excretion. If a substantial portion of clearance does not depend on metabolism, changing enzyme activity may have a smaller overall effect than it would for a drug whose clearance relies mainly on biotransformation. This balance helps explain why similar enzyme changes can produce different exposure patterns among drugs.
CYP450 enzymes and conjugation enzymes represent distinct metabolic pathways, so a change affecting one pathway may not influence another to the same extent. Pathway-specific knowledge therefore strengthens interpretation of fraction metabolized. In clinical development, this distinction helps connect enzyme activity with possible variability in drug exposure and the risk of drug interactions.
Development teams use the measure to connect clearance pathways with anticipated changes in exposure. They can consider how inhibition, induction, or altered organ function might affect a drug when metabolism accounts for a given share of elimination. This supports evaluation of dosing, safety, patient-to-patient variability, and potential drug interactions before or during clinical use.
Differences in enzyme activity can change how much drug undergoes biotransformation, leading to variation in exposure between patients. Fraction metabolized provides a framework for judging how strongly those enzymatic differences may matter for a particular drug. It is therefore useful when assessing variability in response, safety, and the need to consider different dosing requirements.
Organ dysfunction requires attention to the separate clearance routes represented by metabolism and unchanged excretion. Liver dysfunction may alter the metabolic component, whereas kidney dysfunction may affect the route responsible for eliminating unchanged drug. Considering both pathways helps anticipate how exposure and dosing may change, rather than assuming that every drug will respond to organ impairment in the same way.